Skip to content
National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
Division of Cancer Prevention logo
Home Site Map Contact DCP
Programs & Resources
Site Coordinators' Opportunity for Research Excellence (SCORE V) Workshop

Agenda

Monday, February 14, 2005
TimeTopicSpeaker
8:30 - 8:40 amWelcome and Opening RemarksLeslie Ford, MD
8:40 - 9:10 amDCP Chemoprevention OverviewEva Szabo, MD
9:10 - 9:40 amCaBIG: The Impact on Clinical Trials ResearchSue Dubman
9:40 - 10:10 amLOIs, Protocol Review and Approval ProcessErin Iturriaga, RN, CCRC
10:10 - 10:25 amMid- Morning Break
10:25 - 11:10 amRegulatory and Safety: Collaboration between Sponsor and Investigator Linda Doody, PhD
11:10 - 11:40 amCase Report Forms: Common Data ElementsBeverly Meadows, PhDc, RN, OCN
11:40 am - 1:00 pmLunch
1:00 - 1:30 pmRecruitment PlanningDonna Vining, RN, MS
1:30 - 2:30 pmMonitoring Prevention Studies: Role of the Lead Organization Vinita Gotting, MPH, CCRP
Juanita Kim, RN, BSN, OCN
2:30 - 2:45 pmAfternoon Break
2:45 - 3:30 pmMonitoring Prevention Studies: Westat's RoleLaurie Quint- Adler, MPH, RD
3:30 - 4:00 pmMonitoring Prevention Studies: Resources and Next Steps Remote Data Capture Update Questions and Answers Juanita Kim, RN, BSN, OCN
Vinita Gotting, MPH, CCRP

Tuesday, February 15, 2005
TimeTopicSpeaker
8:30 - 8:35 amWelcome and Opening RemarksLeslie Ford, MD
8:35- 9:05 amKeynote How Should We Move the Field of Chemoprevention Agent Development forward in a Productive Manner? Frank Meyskens, MD
9:05 - 9:20 amSymposium: "Biopsy- independent Endpoints for Agent Development"Karen Johnson, MD, PhD, MPH
9:20 - 9:50 am
  • How to Develop and Evaluate An Imaging Endpoint for Prevention Studies
Powel Brown, MD
9:50 - 10:20 am
  • DNA Mutations in Serum as an Endpoint for Prevention Studies
Christopher D Gocke, MD
10:20 - 10:45 amPanel Discussion on Biomarker Development Dr Powel Brown
Dr Christopher Gocke
Dr Scott Lippman
DrHoward Parnes
Moderator: Karen Johnson, MD
10:45 - 11:15 am"Interactive Discussion: Integrating the Statistician into the Protocol Team" Don Corle, MS
11:15 am - 12:00 noon Lunch buffet
12 noon - 2:00 pm Consortia PI Meeting Site Coordinators NIH Tour SCORE Planning Team & Site Coordinators
2:00 - 2:30 pmPI Role in RecruitmentJeff Probstfield, MD
2:30 - 3:00 pmPhase I and II Chemoprevention Clinical Trials Minority Recruitment, Retention, and Adherence Joseph Harrington, BA
3:00 - 3:30 pmRecruitment Role Playing Moderator: Ellen Richmond, RN, MS
3:30 - 3:45 pmRecruitment Panel Discussion
3:45 - 4:00 pmClosing RemarksJudy Smith, RN, MSN
Kathleen Foster, RN, BA


Back to top